Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity
about
Extracellular vesicles as mediators of vascular inflammation in kidney diseaseMicroparticles That Form Immune Complexes as Modulatory Structures in Autoimmune ResponsesMicroparticles as mediators and biomarkers of rheumatic diseaseImproved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseasesExtracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritisThe Inflammatory Role of Platelets: Translational Insights from Experimental Studies of Autoimmune DisordersErosive arthritis and hepatic granuloma formation induced by peptidoglycan polysaccharide in rats is aggravated by prasugrel treatmentElevated Plasma P-Selectin Autoantibodies in Primary Sjögren Syndrome Patients with ThrombocytopeniaSurface complement C3 fragments and cellular binding of microparticles in patients with SLEExtracellular Vesicles: Evolving Contributors in Autoimmunity.Circulating DNA in rheumatoid arthritis: pathological changes and association with clinically used serological markers.Endothelial Alterations in Systemic Lupus Erythematosus and Rheumatoid Arthritis: Potential Effect of Monocyte Interaction.Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles.Flow cytometric analysis of circulating microparticles in plasma.The blood nucleome in the pathogenesis of SLEEarly endothelial damage detected by circulating particles in baboons fed a diet high in simple carbohydrates in conjunction with saturated or unsaturated fat.A caveat for T cell transfer studies: generation of cytotoxic anti-Thy1.2 antibodies in Thy1.1 congenic mice given Thy1.2+ tumors or T cellsMicroparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier functionCirculating microparticles: square the circle.Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations.Microparticles provide a novel biomarker to predict severe clinical outcomes of dengue virus infection.Detection and quantification of microparticles from different cellular lineages using flow cytometry. Evaluation of the impact of secreted phospholipase A2 on microparticle assessmentBench-to-bedside review: circulating microparticles--a new player in sepsis?Nanoparticles isolated from blood: a reflection of vesiculability of blood cells during the isolation processCirculating membrane-derived microvesicles in redox biology.Higher levels of circulating monocyte-platelet aggregates are correlated with viremia and increased sCD163 levels in HIV-1 infection.Impact of smoking in cutaneous lupus erythematosus.Are microparticles the missing link between thrombosis and autoimmune diseases? Involvement in selected rheumatologic diseases.Impact of collection, isolation and storage methodology of circulating microvesicles on flow cytometric analysisAssessment of blood clot formation and platelet receptor function ex vivo in patients with primary Sjogren's syndrome.Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations.Microparticle subpopulations are potential markers of disease progression and vascular dysfunction across a spectrum of connective tissue disease.Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability.Multipotent role of platelets in inflammatory bowel diseases: a clinical approach.Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activityInflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin.Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery.Cell-free and cell-bound circulating nucleic acid complexes: mechanisms of generation, concentration and content.CD154: the atherosclerotic risk factor in rheumatoid arthritis?Microparticle analysis in disorders of hemostasis and thrombosis.
P2860
Q26765072-A3224BF7-FCBC-4BF0-9A6E-BCA51AB0A041Q26795583-FCC33CEF-BC1E-45B3-BDEE-BB417756FAA6Q27016054-B53A681B-8EA3-4D98-BEF9-B4B66B2BB33BQ27335209-9AAFB597-6A31-4213-9628-DB24D6B551E7Q28070177-4D96C571-ABE7-4687-8B70-ABB57FDFB226Q28071325-C39704C0-26CB-47A1-8A3D-D4E789ECA328Q28534529-DDFF58C7-EAB9-4D6D-8F48-42B0A3D311F4Q33427935-F3792BA9-987A-450A-859F-D8C865D08428Q33552712-0333652A-DBE8-428D-85BD-97F29DBAA452Q33579697-739E8606-068E-4EDE-862E-C243E1CAC87CQ33629819-6AF7D46C-F50C-41BF-B968-F181F3AB18B7Q33701603-3FDB11BB-CC1D-44F2-9A78-043E5FCB6854Q34026858-F694E51B-8215-4DFE-8656-1C6F7DDB5434Q34059037-DE6B0CD1-0407-47BF-B4CB-DB17342F75FAQ34415680-8F65893B-4190-45E5-8376-F23445D26712Q34420360-0266FA38-4906-4E70-B4BF-AD33C9FF2AB8Q34510107-A785AB19-5CC7-43E0-91F2-02A7146314C5Q34667556-FE6FFC0F-D9A9-4788-976F-043DD4FFF19FQ34680832-400C2D59-AE9A-4021-B4F6-C70E4FA669FDQ34749444-5932C2E8-ACB2-4271-B6FD-FCE4DCC10ADAQ34991385-4574D42B-656E-41DA-B87A-D12328656730Q35542696-E6636018-2782-4AA2-B6B0-6BAF348C8001Q35559151-1E59FE1B-C0C6-4476-B616-929FDECF4E69Q35576279-DD57186F-9C88-40BA-98CA-5E4A86322D50Q35737756-3F6C5E09-784C-4FF9-9800-344288EE8D79Q35833625-D73A8485-68EA-497F-99B5-7C7A5FF68431Q35842894-35609B82-D2B2-48EE-8C75-8A84E757738DQ35949830-5D59D6FC-D450-4D14-9659-1CFA69D5FFEAQ36336087-AD52C165-E56C-4CAE-A2E4-6E141DBA0D61Q36889466-34E699DC-CE3A-41B2-AB06-027E3E6B2F2CQ37363894-1B13B744-52AD-417B-8425-A2F4EDEEE499Q37544731-B98306EB-A973-48BE-A117-3D6A372966CEQ37632332-FF0D11D1-A0DE-436F-85F0-DB11A28AAE65Q37660674-7C9B1110-7B36-4CAA-9BDC-18B2FA3A7A7CQ37690725-BCAD65CA-00E7-489D-95E1-B69B75AA484DQ37782589-1A5A7AD8-B752-4556-BA77-2C4810897F3AQ37829417-63BBA102-52FD-4AC5-B753-F16B13ED260BQ38002456-DD159F18-7621-4428-B885-F308694F8968Q38083874-B51F42FF-7883-489C-9B7E-32C1803C9667Q38364069-567F05C7-3569-4F4D-8DDE-37D9F18F00EA
P2860
Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased levels of circulatin ...... relation with disease activity
@en
Increased levels of circulatin ...... elation with disease activity.
@nl
type
label
Increased levels of circulatin ...... relation with disease activity
@en
Increased levels of circulatin ...... elation with disease activity.
@nl
prefLabel
Increased levels of circulatin ...... relation with disease activity
@en
Increased levels of circulatin ...... elation with disease activity.
@nl
P2093
P2860
P356
P1476
Increased levels of circulatin ...... relation with disease activity
@en
P2093
Astrid Jüngel
Corinne Miceli Richard
Florence Toti
Jean-Marie Freyssinet
Joelle Benessiano
Jérémie Sellam
Marc Ittah
Steffen Gay
Valérie Proulle
Xavier Mariette
P2860
P2888
P356
10.1186/AR2833
P577
2009-10-15T00:00:00Z
P5875
P6179
1004246128